View More


View More

Welcome to RamanPharma!

Raman Pharma is a UK based MHRA and VMD Licensed Wholesaler supplying to the Human and Veterinary Market. We are a family run company ambitiously changing the face of the Pharmaceutical and Veterinary Market alike in order to serve the needs of our customers and their patients.

Our Philosophy and business are structured around the requirements of our customers and we are committed to giving them our upmost attention and care. We believe in delivering quality and value to our customers wherever they may be.

Our UK and Ireland Products

The Herbal Horse and Pet is a South African manufacturer of a very innovative range of supplements for horses, dogs and cats. Their philosophy of using a large number of different ingredients in small amounts mimics nature in that the healing effect of the ingredients is maximised while undesirable side-effects are minimised. These unique formulations, in conjunction with 21st century scientific research and techniques are what they call “cutting edge nature”.

They are manufactured in a GMP Compliant Factory and has a large following from riders and pet owners across the world. Please follow the link to the website – to see all the amazing blogs and the ability to purchase these products online. The Equine and Pet Range were introduced to the UK Market in September 2014 by Raman Pharma to give the UK a taste of the future in equine and companion animal nutritional supplements.


Pharmacy News
  • Resources available to assist with meeting the diabetes quality criterion from 1st October
    Thursday, September 19, 2019 2:52 pm

    PSNC has published Briefing 043/19: Pharmacy Quality Scheme – Foot and eye screening (retinopathy) checks for patients with diabetes to assist community pharmacy contractors with getting ready to meet the diabetes quality criterion of the Pharmacy Quality Scheme (PQS), which contractors need to start working towards from 1st October 2019. The Briefing explains how to...

  • MHRA Drug Safety Update September 2019
    Thursday, September 19, 2019 2:28 pm

    A new Medicines and Healthcare products Regulatory Agency (MHRA) Drug Safety Update (Vol 13 Issue 1 August 2019) has been published and includes articles on: Hormone replacement therapy (HRT): further information on the known increased risk of breast cancer with HRT and its persistence after stopping Fingolimod (Gilenya▼): increased risk of congenital malformations; new contraindication...

  • CPCF Roadshows: Digital roadshow added to schedule
    Thursday, September 19, 2019 2:03 pm

    Following the announcement of a five-year deal for community pharmacy, PSNC has been holding a series of roadshow events for community pharmacists across England. The events are hosted by PSNC Chief Executive Simon Dukes and his team and are being held to help community pharmacy contractors and anyone working in community pharmacies to understand the...

  • Pharmacy Quality Scheme – Foot and eye screening (retinopathy) checks for patients with diabetes (September 2019)
    Thursday, September 19, 2019 2:46 pm

    This PSNC Briefing provides community pharmacy contractors with guidance on meeting the diabetes quality criterion for the 2019/20 Pharmacy Quality Scheme (PQS), which is one of five quality criteria that community pharmacy contractors will need to meet to be able to claim for the Prevention domain. PSNC Briefing 043/19: Pharmacy Quality Scheme – Foot and...

  • CPCS webinar now on-demand
    Tuesday, September 17, 2019 3:15 pm

    Community pharmacy contractors can now access an online recording of our webinar about the new NHS Community Pharmacist Consultation Service (CPCS). Almost 500 people tuned in to yesterday’s webinar, co-hosted by Alastair Buxton, PSNC’s Director of NHS Services, and colleagues from NHS England and NHS Improvement (NHSE&I). During the webinar, the presenters explained how the...

  • Public Health England distribute tool to aid conversations about ‘productive healthy ageing’
    Tuesday, September 17, 2019 2:16 pm

    In a follow up from its guidance A Menu of Interventions for Productive Healthy Ageing, published in March 2019, Public Health England (PHE) has distributed* sets of cards which provide information to pharmacy teams on how to support older people to improve the quality of their lives. These cards are designed to guide conversations with...

  • Pharmacy inspection reports made public
    Tuesday, September 17, 2019 11:37 am

    The General Pharmaceutical Council (GPhC) has begun making pharmacy inspection reports available in the public domain. A new website has been created to enable members of the public to view redacted copies of inspection reports. Visitors will be told whether a pharmacy has met or not met all of the core standards for registered pharmacies, as...

  • PQS: Updated resources available on the asthma quality criterion
    Tuesday, September 17, 2019 10:05 am

    Support is now available from PSNC and on PharmOutcomes to assist community pharmacy contractors with meeting the asthma quality criterion of the 2019/20 Pharmacy Quality Scheme. Contractors are therefore encouraged to review this support and consider implementing a process (many contractors may already have a process in place to identify patients to meet this criterion, as...

  • Pharmacy Quality Scheme – Asthma referrals (September 2019)
    Tuesday, September 17, 2019 9:52 am

    This PSNC Briefing provides contractors with guidance for the 2019/20 Pharmacy Quality Scheme (PQS) on meeting the Asthma domain. PSNC Briefing 042/19: Pharmacy Quality Scheme – Asthma referrals If you have any queries on this PSNC Briefing or you require more information, please contact the PSNC Services Team. To browse other PSNC briefings on services and commissioning click...

  • Shortage Notice: Tiagabine (Gabitril) 5mg, 10mg and 15mg tablets
    Monday, September 16, 2019 12:43 pm

    Teva,  the sole manufacturers of Tiagabine (Gabitril) 5mg, 10mg and 15mg tablets, are currently experiencing temporary supply disruptions. Teva,  the sole manufacturers of Tiagabine (Gabitril) 5mg, 10mg and 15mg tablets have advised a resupply date of end of October 2019 Supplies are available from specialist importers on an ‘unlicensed’ basis. Ensure that where a prescriber...

MHRA Regulatory News
VMD Regulatory News
Global Pharmaceutical News


Unit 2 Fleet Business Park, Sandy Lane, Church Crookham, Fleet, Hampshire, GU52 8BF


Pharmaceutical and Veterinary Licensed Distributor. WDA (H) 43703 & WDA (V) 43703.


- +44 (0)1252 260 460.
- +44 (0)1276 469 290


Monday to Friday - 09:30 – 18:30
Saturday & Sunday - Closed, Online Ordering Available